01
Essential markets
Businesses supporting medicines, manufacturing, distribution, and critical healthcare infrastructure.
NASDAQ: DMAA
Advancing a stronger pharmaceutical future.
A purpose-led acquisition platform focused on identifying high-quality pharmaceutical businesses with the potential to strengthen domestic supply, innovation, and resilience.
Explore our approach →Investment thesis
A disciplined path to long-term value.
We evaluate businesses through a focused lens: durable demand, differentiated capabilities, responsible leadership, and a credible path to public-market growth.
02
Operational strength
Platforms with proven teams and the capacity to scale through disciplined execution.
03
Domestic resilience
Opportunities aligned with a more reliable and secure U.S. pharmaceutical ecosystem.
04
Public readiness
Clear governance, transparent reporting, and a strategy designed for long-term shareholders.
Leadership
Experience at the intersection of healthcare and capital markets.
Our team brings together transaction, operating, regulatory, and public-company experience to evaluate opportunities with rigor.
View corporate updatesLatest information
News & filings
CorporateCompany overview and strategic focusRead →
InvestorsSEC filings and governance materialsView →
ContactInvestor and media inquiriesConnect →